rs1442611750
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_014915.3(ANKRD26):c.4336A>G(p.Lys1446Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K1446Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_014915.3 missense
Scores
Clinical Significance
Conservation
Publications
- thrombocytopenia 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- acute myeloid leukemiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- autosomal thrombocytopenia with normal plateletsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary thrombocytopenia and hematologic cancer predisposition syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014915.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKRD26 | NM_014915.3 | MANE Select | c.4336A>G | p.Lys1446Glu | missense | Exon 30 of 34 | NP_055730.2 | ||
| ANKRD26 | NM_001256053.2 | c.4333A>G | p.Lys1445Glu | missense | Exon 30 of 34 | NP_001242982.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ANKRD26 | ENST00000376087.5 | TSL:5 MANE Select | c.4336A>G | p.Lys1446Glu | missense | Exon 30 of 34 | ENSP00000365255.4 | ||
| ANKRD26 | ENST00000436985.7 | TSL:1 | c.4333A>G | p.Lys1445Glu | missense | Exon 30 of 34 | ENSP00000405112.3 | ||
| ANKRD26 | ENST00000676280.1 | c.163A>G | p.Lys55Glu | missense | Exon 2 of 4 | ENSP00000502438.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248842 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461222Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726922 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.K1446E variant (also known as c.4336A>G), located in coding exon 30 of the ANKRD26 gene, results from an A to G substitution at nucleotide position 4336. The lysine at codon 1446 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
not specified Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at